SEC Tracker
Get the app
GIPL · XBRL financial data

Global Innovative Platforms financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (GIPL's year ends in late September)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Revenue0*0000*—000*3010751
Research and development————year only3449362*1123
General and administrative124*494676*120151212(148)*69——
Total operating expenses124*494676*120151212235*79258292
Operating income (loss)(124)*(49)(4)(6)(76)*(120)(151)(212)(235)*(49)(151)(242)
Other income (expense)0*0000*———————
Income tax expense (benefit)0*0000*—00——00
Net income (loss)(124)*(49)(4)(6)(76)*(120)(151)(212)(235)*(49)(151)(242)
Earnings per share, basic USD per share(0.20)*(0.00)0.000.000.00*(0.00)(0.00)(0.01)(0.01)*(0.00)(0.00)(0.01)
Earnings per share, diluted USD per share(0.20)*(0.00)0.000.000.00*(0.00)(0.00)(0.01)(0.01)*(0.00)——
Weighted average shares, basic thousands of shares619*20,63727,31027,31031,261*35,74538,42740,43842,857*44,53546,71648,777
Weighted average shares, diluted thousands of shares619*20,63727,31027,31031,261*35,74538,42740,43842,857*44,53500

Balance sheet

CSV

Fiscal quarters (GIPL's year ends in late September)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Cash and cash equivalents0211001481561981849327244
Accounts receivable————————0—1815
Total current assets02110014816720919955367271
Property and equipment, net000000000170222265
Total assets021100148167209199225592539
Accounts payable3121319114230000
Accrued liabilities————0———10722
Total current liabilities3641982012173314328126628
Total liabilities3641982012173314328126628
Accumulated deficit(401)(450)(454)(461)(537)(658)(809)(1,021)(1,255)(1,305)(1,456)(1,698)
Total stockholders' equity(364)(197)(200)(207)(33)134164181188160590531
Total liabilities and equity021100148167209199225592539
Common shares outstanding (cover page) thousands of shares27,84127,84127,84127,84136,24539,11140,85842,18146,75447,53249,10349,751

Cash flows

CSV

Fiscal quarters (GIPL's year ends in late September)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Net income (loss)(124)*(49)(4)(6)(76)*(120)(151)(212)(235)*(49)(151)(242)
Net cash from operating activities(76)*(25)(3)*(0)*(60)*(138)(174)*(184)*(65)*13(149)*(134)*
Purchases of property and equipment———————0*———55*
Net cash from investing activities0*00*0*0*——0*(175)*——(55)*
Proceeds from issuing common stock———(0)*———227*———106*
Net cash from financing activities76*262*10*50*287181*227*60*19496*106*
Net change in cash———————42*———(83)*

Compare with peers

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
  • A cell reading “not reported” means the filings give no figure for that quarter alone.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
Global Innovative Platforms24451(134)*49.8M1.8 quarters 10-QJun 30, 2026
Interpace Biosciences2,6889,13198*27.7M— 10-QJun 30, 2026
ENDRA Life Sciences1,740not reported(928)*1.5M1.9 quarters 10-QJun 30, 2026
Bluejay Diagnostics9,599not reported(1,499)*4.5M6.4 quarters 10-QJun 30, 2026
Stimcell Energetics6.9not reported(109)21.1M0.1 quarters 10-QAug 31, 2026
LogicMark3,4963,34983*899,759— 10-QJun 30, 2026
INVO Fertility3,7332,175(1,101)*2.5M3.4 quarters 10-QJun 30, 2026
Nu-Med Plus5.401.1*83.5M— 10-QJun 30, 2026
STRATA Skin Sciences7,9129,292*(239)*5.9M33.1 quarters 10-KDec 31, 2025

Not investment advice. Not affiliated with the U.S. SEC.